News
The End Prescription Drug Ads Now Act aims to eliminate direct-to-consumer drug advertising across all media platforms, ...
Eli Lilly & Co. and health tech company Kalderos Inc. are seeking to revive lawsuits in the DC Circuit after a federal judge ...
Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...
Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...
Industry sources reveal drug companies have stopped negotiating listings on the PBS and in some cases are considering not ...
Eli Lilly ( LLY 0.36%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results